Template:Pediatric VP shunt infections: Difference between revisions
(Created page with "*Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24 *Always involved neurosurgery in management *Tailor antimicrobia...") |
(Convert to AntibioticDose with disease=Ventriculoperitoneal shunt infection) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
*Empiric therapy: Vancomycin AND Cefotaxime | *Empiric therapy: {{AntibioticDose|disease=Ventriculoperitoneal shunt infection|drug=Vancomycin|dose=age-based dosing|context=Empiric with Cefotaxime or Ceftriaxone|population=Pediatric}} AND {{AntibioticDose|disease=Ventriculoperitoneal shunt infection|drug=Cefotaxime|dose=200mg/kg/day IV div q6hrs|context=Empiric with Vancomycin|population=Pediatric}} OR {{AntibioticDose|disease=Ventriculoperitoneal shunt infection|drug=Ceftriaxone|dose=100mg/kg/day IV div q12-24hrs|context=Empiric with Vancomycin|population=Pediatric}} | ||
*Always | *Always involve neurosurgery in management | ||
*Tailor antimicrobial therapy to culture results | *Tailor antimicrobial therapy to culture results | ||
Latest revision as of 01:49, 20 March 2026
- Empiric therapy: Vancomycin age-based dosing AND Cefotaxime 200mg/kg/day IV div q6hrs OR Ceftriaxone 100mg/kg/day IV div q12-24hrs
- Always involve neurosurgery in management
- Tailor antimicrobial therapy to culture results